| Bioactivity | AQ-13 dihydrochloride is an aminoquinoline antimalarial drug that is effective against drug-resistant strains of Plasmodium falciparum. |
| In Vivo | Slight decreases in the PCE/RBC ratio are observed in male and female rats treated with CQ and in females only treated with AQ-13; however, none of these changes is statistically significant[1]. |
| Name | AQ-13 dihydrochloride |
| CAS | 169815-40-1 |
| Formula | C16H24Cl3N3 |
| Molar Mass | 364.74 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Riccio ES, et al. Genetic toxicology testing of the antimalarial drugs chloroquine and a new analog, AQ-13. Environ Mol Mutagen. 2001;38(1):69-79. |
AQ-13 dihydrochloride
CAS: 169815-40-1 F: C16H24Cl3N3 W: 364.74
AQ-13 dihydrochloride is an aminoquinoline antimalarial drug that is effective against drug-resistant strains of Plasmod
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.